These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2174203)

  • 1. Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Khatib R
    Am Heart J; 1990 Dec; 120(6 Pt 1):1377-81. PubMed ID: 2174203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Khatib R
    Circulation; 1990 Mar; 81(3):1039-46. PubMed ID: 2155071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model.
    Rezkalla S; Khatib R; Khatib G; Smith F; Walsh M; Sowers J; Kloner R
    J Lab Clin Med; 1988 Jul; 112(1):118-21. PubMed ID: 2839587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Smith FE; Khatib R
    J Am Coll Cardiol; 1988 Aug; 12(2):412-4. PubMed ID: 2839568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal ventricular thinning caused by indomethacin in the late phase of coxsackievirus B4 murine myocarditis.
    Khatib R; Reyes MP; Khatib G; Smith F; Rezkella S; Kloner RA
    Am J Med Sci; 1992 Feb; 303(2):95-8. PubMed ID: 1311498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of captopril in coxsackievirus myocarditis.
    Matsumori A; Suzuki H; Kawai C
    Circulation; 1990 Nov; 82(5):1882-3. PubMed ID: 2171809
    [No Abstract]   [Full Text] [Related]  

  • 7. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
    Glück B; Dahlke K; Zell R; Krumbholz A; Decker M; Lehmann J; Wutzler P
    J Med Virol; 2010 Dec; 82(12):2043-52. PubMed ID: 20981792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
    Latva-Hirvelä J; Kytö V; Saraste A; Vuorinen T; Levijoki J; Saukko P
    Eur J Clin Invest; 2009 Oct; 39(10):876-82. PubMed ID: 19772522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis.
    Takada H; Kishimoto C; Hiraoka Y; Kurokawa M; Shiraki K; Sasayama S
    Am J Physiol; 1997 Jan; 272(1 Pt 2):H211-9. PubMed ID: 9038940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice.
    Marton J; Albert D; Wiltshire SA; Park R; Bergen A; Qureshi S; Malo D; Burelle Y; Vidal SM
    PLoS One; 2015; 10(9):e0138222. PubMed ID: 26375467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis.
    Costanzo-Nordin MR; Reap EA; O'Connell JB; Robinson JA; Scanlon PJ
    J Am Coll Cardiol; 1985 Nov; 6(5):1078-82. PubMed ID: 2995470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
    Cardiovasc Res; 1992 Oct; 26(10):956-61. PubMed ID: 1336713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
    Yue-Chun L; Teng Z; Na-Dan Z; Li-Sha G; Qin L; Xue-Qiang G; Jia-Feng L
    PLoS One; 2012; 7(6):e39394. PubMed ID: 22761780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successive infection of coxsackievirus B3 and encephalomyocarditis virus: an animal model of chronic myocarditis.
    Okada I; Matsumori A; Tomioka N; Kawai C
    J Pathol; 1992 Jul; 167(3):341-7. PubMed ID: 1325552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
    Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice.
    Matsumori A; Tomioka N; Kawai C
    Am Heart J; 1988 Jun; 115(6):1229-32. PubMed ID: 2837073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
    Kishimoto C; Thorp KA; Abelmann WH
    Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of verapamil on acute coxsackievirus B3 murine myocarditis.
    Xu Y; Yang YZ; Chen HZ; Jin PY; Guo Q; Zhao WZ; Yang JH; Cai QX; Zhou YC
    Chin Med J (Engl); 1992 Oct; 105(10):818-21. PubMed ID: 1337875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
    Eur Heart J; 1995 Dec; 16(12):1900-6. PubMed ID: 8682024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.